News

March 7, 2018March 7, 2018

Cancer Survivors Need More Focus on Non-medical Needs and Policies

News

As more people are surviving cancer, support networks and research are becoming increasingly insufficient, particularly in relation to non-medical issues like access to jobs and loans. That theme was highlighted ... Read more

March 6, 2018March 6, 2018

Proposed Guideline Urges Caution Prescribing Cannabis in Canada

News

A proposed guideline focusing on the use of cannabinoid medical products says there is some evidence they benefit patients with chemotherapy-induced nausea and vomiting, which is particularly relevant for patients with ... Read more

March 5, 2018March 5, 2018

Stem Cell Transplants Can Benefit Lymphoma Patients Who Fail to Respond to Chemo, Study Shows

News

Stem cell transplants can lead to excellent outcomes in certain B-cell lymphoma patients who failed to respond to chemoimmunotherapy, a study shows. The results apply to patients with primary mediastinal B-cell lymphoma, ... Read more

March 2, 2018March 2, 2018

Researchers Discover a Non-invasive and Safe Way to Assess Stem Cell Transplants Earlier

News

An imaging agent called 18F-fluorothymidine (18F-FLT) allows researchers to assess how a patient is recovering after receiving a stem cell transplant earlier than current methods, according to a pilot study. ... Read more

March 1, 2018March 1, 2018

Johns Hopkins Team Calls for Standardized Hospital Charges for Outpatient Cancer Care

News

A study showing wide disparities in hospitals’ charges for outpatient cancer care has prompted Johns Hopkins researchers to call for standardized prices for the services. The team also expressed concern ... Read more

February 28, 2018February 28, 2018

Age Alone Shouldn’t Exclude Non-Hodgkin’s Lymphoma Patients from Stem Cell Transplants, Study Finds

News

When choosing which patients are eligible for blood stem cell transplants, age is usually one of the factors weighed in. Now, a new study shows that at least for patients ... Read more

February 27, 2018

Phase 2 Study of KD025 Shows Encouraging Clinical Response in Patients with Graft-versus-host Disease

News

Treatment with KD025 is safe and effectively reduces the manifestations of graft-versus-host disease in patients receiving steroids for the condition, or whose condition worsened while on steroids, Kadmon Holdings announced. Those findings ... Read more

February 26, 2018February 26, 2018

Umbralisib Shows Promise in Treating Lymphoma, Leukemia in Phase 1 Clinical Trial

News

Umbralisib, being developed by TG Therapeutics, showed positive results in the treatment of chronic lymphocytic leukemia and lymphoma patients in a Phase 1 clinical trial. The study, “Umbralisib, a novel ... Read more

February 23, 2018February 23, 2018

Imbruvica Only Moderately Effective in Relapsed Follicular Lymphoma Patients, Phase 2 Trial Shows

News

Imbruvica (ibrutinib) is only moderately effective against tumors in patients with relapsed follicular lymphoma, and certain clinical and genetic factors may have an impact on patient response, according to results ... Read more

February 21, 2018February 21, 2018

New Technology Identifies Hodgkin’s Patients Unlikely to Respond to Chemotherapy, Company Says

News

A new technology called Telo-HL, developed by 3D Signatures (3DS), is able to distinguish Hodgkin’s lymphoma patients who respond to standard chemotherapy from those who do not, the company announced. An independent analysis ... Read more